论文部分内容阅读
目的 :研究盐酸伐昔洛韦治疗复发性生殖器疱疹的临床效果。方法 :从我院2012年4月~2013年4月期间收治的复发性生殖器疱疹患者中随机抽取62例作为研究对象,分为两组,给予研究组盐酸伐昔洛韦治疗,对照组采用阿昔洛韦治疗,回顾分析两组临床治疗的效果。结果 :治疗后,研究组总有效率及复发率分别为96.77%、22.58%,与对照组83.87%、41.94%比较,差异存在统计学方面的意义(P<0.05)。结论:给予盐酸伐昔洛韦治疗复发性生殖器疱疹的临床效果较为显著,无明显不良反应,且复发率低,值得在临床上推广应用。
Objective: To study the clinical effect of valacyclovir hydrochloride in the treatment of recurrent genital herpes. Methods: From April 2012 to April 2013 in our hospital recurrent genital herpes patients were randomly selected 62 cases were divided into two groups, given the study group valacyclovir hydrochloride treatment, the control group using A Cyclocarb treatment, review the effect of two groups of clinical treatment. Results: After treatment, the total effective rate and recurrence rate in the study group were 96.77% and 22.58%, respectively, which were statistically significant compared with 83.87% and 41.94% in the control group (P <0.05). Conclusion: The clinical effect of valacyclovir hydrochloride in the treatment of recurrent genital herpes is more obvious, without obvious adverse reactions, and the recurrence rate is low, so it is worth popularizing and applying in clinic.